Results 231 to 240 of about 299,857 (400)

Mapping developmental transitions in mental health from mid‐ to late‐adolescence: Concurrent and longitudinal links to cognition

open access: yesJCPP Advances, EarlyView.
Abstract Background Developmental changes in mental health are mostly mapped between childhood and adolescence or childhood and adulthood. This study maps developmental transitions in mental health profiles from mid‐ to late‐adolescence, exploring how these transitions relate to cognitive function in mid‐adolescence. Method Participants from the IMAGEN
Silvana Mareva   +24 more
wiley   +1 more source

Genetic influences on suicide attempt in adolescence: Evaluating mediation by impulsivity and painful and provocative events

open access: yesJCPP Advances, EarlyView.
Impulsivity and exposure to painful and provocative events each contribute to risk for suicide attempt. However, there is little support for the hypothesis that genetic influences on suicide attempt are mediated by impulsivity and painful and provocative event exposure in early adolescence.
Mallory Stephenson   +2 more
wiley   +1 more source

A comprehensive longitudinal analysis of changes during Attention Deficit Hyperactive Disorder pharmacological treatments: Relationships between clinical measures, QbCheck and Conners CPT‐II

open access: yesJCPP Advances, EarlyView.
Abstract Background This study aims to evaluate the clinical value of using QbCheck in routine Attention Deficit Hyperactive Disorder (ADHD) clinics by investigating longitudinal inter‐domain relationships between objective neurocognitive outcomes of QbCheck and subjective clinical outcomes: ADHD core symptoms, impairment and quality of life (QoL ...
Seungjae Lee   +3 more
wiley   +1 more source

Systematic review: Safety and efficacy of atomoxetine in children and adolescents with autism spectrum disorder

open access: yesJCPP Advances, EarlyView.
This systematic review aimed to assess the current evidence on the efficacy and safety of Atomoxetine in common clinical symptoms of autism spectrum disorder (ASD) for children and adolescents. With limited studies available, there is a need for more high‐power studies for the use of Atomoxetine in children and adolescents with autism spectrum disorder.
Nihit Gupta   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy